Marc Wagner's knowledge of pharmaceutical compliance adds value to his developing practice. He has experience performing research on FDA guidance documents, food additives and standards of identity, Prescription Drug Monitoring Programs, Investigational New Drug Applications, and state board of pharmacy rules and regulations. Additionally, Marc's educational and professional background in pharmacy provides him with a substantial understanding of a variety of pharmaceutical compliance measures, including pharmaceutical compounding, 503B Outsourcing Facilities, pharmacy reimbursement, FDA labeling requirements, HIPAA standards, and Drug Enforcement Administration requirements.
*Not admitted in the District of Columbia, admitted in Pennsylvania. Practicing pursuant to D.C. Rule 49(c)(8) under the direct supervision of Lee Rosebush during pendency of application for admission to the District of Columbia.